Crowdonomics
All companies
Carnyx Therapeutics, Ltd logo

Carnyx Therapeutics, Ltd

Operating

Indianapolis, IN

Visit website
Latest valuation
—
No round has disclosed a priced valuation or cap.
Total raised
$0
Across 1 round since 2025
Latest share price
$1.87
Reg CF Offering (2025) offering price

Financials

FY2023–FY2024 · from SEC filings · hover any figure for its source
$0
2023
$0
−$547K
2024
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2023
FY2024
Income statement
Revenue
$0
$0
Cost of goods sold
$0
$0
Net income
$0
-$547,219
Taxes paid
$0
$0
Balance sheet
Cash
$0
$1,839,565
Accounts receivable
$0
$5,540
Total assets
$0
$1,845,105
Short-term debt
$0
$138,234
Long-term debt
$0
$2,172,500
Total liabilities
$0
$2,310,734
Other
Headcount
—
0

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Fundraising history

Reg CF Offering (2025)OpenReg CF · Common Equity · via Equifund Crowd Funding Portal Inc.
Raised $0 / $5M

Team

5 people
/s/ Patrick Gunning
Chief Executive Officer
/s/ Elvin de Araujo
Chief Operating Officer and Director
/s/ Mark Bell
Chief Development Officer
/s/ Mark Lindsay
Chief Innovation Officer and Director
/s/ Terry Butler
Chief Financial Officer

Names and titles as disclosed on SEC Form C. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Not obligated

never closed a Reg CF raise

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

SEC filings

  • Form CDec 3, 20250001640334-25-002246
    EDGAR
Source: SEC EDGARCIK 0002098209DEShare price $1.87Last synced Aug 17, 2026

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.